KMA Holding, Inc.
MCDA
Other OTC0.00
USD
- -
- -
ISIN
US48254P1066
CUSIP
48254P106
Return %
Stock
S&P500
1Y
0.00
26.53
3Y
- -
76.60
5Y
-98.57
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Ronald Ritter
- Full Time Employees
- 10
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 4701 North Federal Highway Pompano Beach FL United States of America 33064
- IPO Date
- Aug 4, 2010
- Website
- kmaholding.com
- Similar Companies
- Business
- KMA Holding, Inc. (MCDA) is a diversified holding company focused on the development, manufacturing, and distribution of medical test kits and related healthcare products. Through its wholly owned subsidiaries Lyfetec, Inc. and Pembroke Gun and Range, the company manufactures human and pet home medical test kits for detecting drugs of abuse, sexually transmitted diseases, infectious diseases, tumor markers, fertility issues, cancer, diabetes, and Lyme disease via analysis of blood, saliva, urine, hair, and other substances; pet home medical test kits for cancer, diabetes, and Lyme disease; emergency response mobile hospital units providing temporary life support, medical and pharmaceutical products, services, and secured wireless communication; and sporting goods assembly. Founded in 2000 and headquartered at 4701 North Federal Highway, Suite 430, Pompano Beach, Florida, with additional references to Fort Lauderdale and Temecula operations, KMA Holding targets national and international medical, healthcare equipment, and distribution services markets. Formerly known as Macada Holdings Inc., the company changed its name to KMA Holding, Inc. in March 2011, marking its most recent noted structural change, with no publicly reported major acquisitions, funding rounds, partnerships, new product launches, or strategic expansions within the last 1-2 years.